Vescor Therapeutics

United Kingdom
Newyork, Argyll and Bute, United Kingdom, 10017

Company profile

Vescor Therapeutics company profile

Vescor Therapeutics is an autophagy-targeted therapeutic designed to assist in cancer treatment. It offers clinical studies that have now shown a requirement for autophagy in sustaining tumour growth as well as the mechanism of resistance to a number of currently used therapies.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Founded
2017-01-11

Headquarters

Postal code
10017
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2017-01-11
Last equity funding
Seed
Investors
1
Lead investors
1

Founders and investors

Lead investors

Deerfield

Investors

Deerfield